AGL Stock Overview
ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products.
+ 2 more risks
ANGLE plc Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||UK£0.67|
|52 Week High||UK£1.64|
|52 Week Low||UK£0.61|
|1 Month Change||-3.18%|
|3 Month Change||-31.28%|
|1 Year Change||-50.37%|
|3 Year Change||-14.10%|
|5 Year Change||72.24%|
|Change since IPO||-55.18%|
Recent News & Updates
|AGL||GB Medical Equipment||GB Market|
Return vs Industry: AGL underperformed the UK Medical Equipment industry which returned -20% over the past year.
Return vs Market: AGL underperformed the UK Market which returned -15.1% over the past year.
|AGL Average Weekly Movement||7.8%|
|Medical Equipment Industry Average Movement||6.0%|
|Market Average Movement||5.4%|
|10% most volatile stocks in GB Market||10.7%|
|10% least volatile stocks in GB Market||2.8%|
Stable Share Price: AGL is more volatile than 75% of UK stocks over the past 3 months, typically moving +/- 8% a week.
Volatility Over Time: AGL's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of UK stocks.
About the Company
|1994||128||Andrew David Newland||https://angleplc.com|
ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD multiplex analysis system for routine and focused multiplex analysis of DNA, RNA or protein biomarkers. The company was founded in 1994 and is based in Guildford, the United Kingdom.
ANGLE plc Fundamentals Summary
|AGL fundamental statistics|
Is AGL overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|AGL income statement (TTM)|
|Cost of Revenue||UK£1.04m|
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
|Earnings per share (EPS)||-0.064|
|Net Profit Margin||-1,456.87%|
How did AGL perform over the long term?See historical performance and comparison